A treatise on hazards of endocrine disruptors and tool to evaluate them

Indian Journal of Experimental Biology

Volumn 43, Issue 11, 2005, Pages 975-992

  Roy, Partha ^a   Pereira, Ben M J ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

Endocrine disruption; Phytoestrogen; Reproduction; Steroid receptors Xenobiotics

Indexed keywords

GLUCOCORTICOID; HORMONE; PHYTOESTROGEN; XENOBIOTIC AGENT;

ANIMAL; BIOASSAY; CHEMICAL MODEL; DOSE RESPONSE; DRUG EFFECT; ENDOCRINE SYSTEM; ENVIRONMENT; HUMAN; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; POLLUTANT; REVIEW; SPERMATOZOON;

ANIMALS; BIOLOGICAL ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE SYSTEM; ENVIRONMENT; ENVIRONMENTAL POLLUTANTS; GLUCOCORTICOIDS; HORMONES; HUMANS; MALE; MODELS, CHEMICAL; PHYTOESTROGENS; SPERMATOZOA; XENOBIOTICS;

ANIMALIA;

EID: 27644559392     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (160)

1. Greenspan F S & Gordon J S, Introduction to endocrinology. in Basic & clinical endocrinology, edited by Reinhardt, Reinhardt S, Langan S (Appleton & Lange, Stamford)1.
2. Witorsch, R J, Endocrine disruptors: Can biological effects and environmental risks be predicted? Regul Toxicol Pharmacol, 36 (2002) 118.
3. Jacobs M N & Lewis D F V, Steroid hormone receptors and dietary ligands: Selected review, Prog Nutr Soc, 61 (2002) 105.
4. Akingbemi B T & Hardy M P, Oestrogenic and antiandrogenic chemicals in the environment: Effects on male reproductive health, Annals Med, 33 (2001) 391.
5. Eertmans F, Dhooge W, Stuyvaert S & Comhaire F, Endocrine disruptors: effects on male fertility and screening tools for their assessment, Toxicol in Vitro, 17 (2003) 515.
6. Mori C, Possible effects of endocrine disruptors on male reproductive function, Acta Anat Nippo, 76 (2001) 361.
7. Couse J F & Korach K S, Estrogen receptor null mice: what have we learned and where will they lead us? Endocrine Rev, 20 (1999) 358.
8. Norgil D, Main K M, Toppari J & Skakkabaek N E, Impact of exposure to endocrine disruptors in utero and in childhood on adult reproduction, Best Practice Res Clin Endocrinol Metab, 16 (2002) 289.
9. Cowley S M, Hoare S, Mosselman S & Parker M G, Estrogen receptors alpha and beta form heterodimers on DNA, J Biol Chem, 272 (1997) 863.
10. Pettersson K, Grandien K, Kuiper G G & Gustafsson J A, Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha, Mol Endocrinol, 11 (1997) 1486.
11. Hubbard R E, Bonn T, Engstrom O, Ohman L, Greene G L, Gustafsson J A & Carlquist M, Molecular basis of agonism and antagonism in the estrogen receptor, Nature, 389 (1997) 1486.
12. Pike A C, Brzozowski A M, Walton J, Hubbard R E, Bon T, Gustafsson J A & Carlquist M, Structural aspects of agonism and antagonism in the estrogen receptor, Biochem Soc Trans, 28 (2000) 396.
13. Pike A C, Brzozowski A M, Hubbard R E, Thorshell A G, Engstrom O, Ljunggren J, Gustafsson J A & Carlquist M, Structure of the ligand-binding domain of estrogen receptor beta in the presence of a partial agonist and a full antagonist, Embo J, 18 (1999) 4508.
14. Wong C W, Komm B & Cheskis B J, Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators, ER selective ligands, Biochemistry, 40 (2001) 909.
15. Bramlett K S, Wu Y & Burris T P, Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes, Mol Endocrinol, 15 (2001) 909.
16. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M & Gustafsson J A, Mechanisms of estrogen action, Physiol Rev, 81 (2001) 909.
17. Kirk C J, Harris R M, Wood D M, Waring R H & Huges P J, Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogen? Biochem Soc Trans, 29 (2001) 209.
18. Krazeisen A, Breitling R, Moller G & Adamski J, Phytoestrogens inhibit human 17beta -hydroxysteroid dehydrogenase type 5, Mol Cell Endocrinol, 171 (2001) 151.
19. Le Bail J C, Champavier Y, Chulia A J & Habrioux G, Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells, Life Sci, 66 (2000) 1281.
20. Mueller S O, Kling M, Arifin Firzani P, Meckey A, Duranti E, Shields-Botella J, Delansorne R, Broschard T & Kramer P J, Activation of estrogen receptor alpha and ERbeta by 4 methylbenzylidene-camphor in human and rat cells: comparison with phyto- and xenoestrogen, Toxicol Lett, 142 (2003) 89.
21. Milligan S R, Khan O & Nash M, Competitive binding of xenobiotic oestrogen to rat alpha-fetoprotein and to sex steroid binding protein in human and rainbow trout (Onchorhynchus mykiss) plasma, Gen Comp Endocrinol, 112 (1998) 300.
22. Abraham I M, Han S K, Todman M G, Korach K S & Herbison A E, Estrogen receptor beta mediates rapid estrogen action on gonadotropin releasing hormone neurons in vivo, J Neurosci, 23 (2003) 5771.
23. Fin D A, Ford M M, Wiren K M, Roselli C E & Crabbe J C, The role of pregnane nuerosteroids in ethanol withdrawal: Behavioral genetic approaches, Pharmacol Ther, 101 (2004) 91.
24. Turner K J, McIntyre B S, Phillips S L, Barlow N J, Bowman C J & Foster P M D, Altered gene expression during rat Wolffian duct development in response to in utero exposure to the antiandrogen linuron, Toxicol Sci, 74 (2003) 114.
25. Silva E, Rajapakse N & Kortenkamp A, Something from "nothing"- 8 weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects, Environ Sci Technol, 36 (2002) 1751.
26. Markey C M, Rubin B S, Soto A M & Sonnenschein C, Endocrine disruptors: from Wingspread to environmental developmental biology, J Steroid Biochem Mol Biol, 83 (2003) 235.
27. vom Saal E S, Timmus B G, Montano M M, Palanza P, Thayer K A, Nagel S C, Ganjam V K, Parmigiani S & Welshons W V, Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbesterol and opposite effects at high dose, Proc Natl Acad Sci USA, 94 (1997) 2056.
28. Nagel S C, vom Saal F S, Thayer K A, Dhar M G, Boechler M & Welshons W V, Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens, bisphenol A and octylphenol, Environ Health Prespect, 105 (1997) 70.
29. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report, (US Environmental Protection Agency, Washington, DC), 1998.
30. Sonnenschein C, Olea N, Pasanen M E & Soto A M, Negative controls of cell proliferation: Human prostrate cancer cells and androgens, Cancer Res, 49 (1989) 3474.
31. Geck P, Maffini M V, Szelei J, Sonnenschein C & Soto A M, Androgen-induced proliferative quiescence in prostate cancer: the role of AS3 as its mediator, Proc Natl Acad Sci USA, 97 (2000) 10185.
32. McLachlan J A, Newbold R R, Burow M E & Li S F, From malformations to molecular mechanisms in the male: three decades of research on endocrine disruptors, APMIS, 109 (2001) 263.
33. Anderson L M, Introduction and overview: Perinatal carcinogenesis: growing nodes for epidemiology, risk management and animal studies, Toxicol Appl Pharmacol, 199 (2004) 85.
34. Newbold P R, Lessons learned from the perinatal exposure to DES, Toxicol Appl Pharmacol, 199 (2004) 142.
35. Ternes T A, Kreckel P & Mueller J, Behavior and occurrence of estrogen in municipal sewage treatment plants-11. Aerobic batch experiments with activated sludge, The Sci Total Environ, 225 (1999) 91.
36. Tabak H H & Bunch R L, Steroid hormones as water pollutants I: metabolism of natural and synthetic ovulation inhibiting hormones by microorganisms of activated sludge and primary settled sewage, Dev Indus Microbiol, 11 (1970) 367.
37. Kuch H M & Ballschmityer K, Determination of endocrine-disrupting phenolic compounds and estrogens in surface and drinking water by HRGG-(NCI)-MS in the pictogram per liter range, Environ Sci Tech, 35 (2001) 3201.
38. Cargouet M, Perdiz D, Mouatassium-Souali A, Tamisierkarolak S & Levi Y, Assessment of river contamination by estrogenic compounds in Paris area (France), Sci Total Environ, 324 (2004) 55.
39. Soto A M, Calabro J M, Prechtl N V, Yau A Y, Edward R O, Daxenberger A, Kolok A S, Guillette L J Jr, Bizec le B, Lange I G & Sonnenschein C, Androgenic and estrogenic activity in water bodies receiving cattle feedlot effluent in Eastern Nebraska, USA, Environ Health Prespect, 122 (2004) 346.
40. Thomas K V, Balaam J, Hurst M R & Thain J E, Identification of in vitro estrogen and androgen receptor agonist in North Sea offshore produced water discharges, Environ Toxicol Chem, 23 (2004) 1156.
41. Sheahan D A, Brighty G C, Daniel M, Jobling S, Harries J E, Hurst M R, Kennedy J, Kirby S J, Morris S, Routledge E J, Sumpter J P & Waldock, M J, Reduction in the estrogenic activity of a treated sewage effluent discharge to an English river as a result of a decrease in the concentration of industrially derived surfactant, Environ Toxicol Chem, 21 (2002) 515.
42. Shore L S, Gurevitz M & Shernesh M, Oestrogen as an environmental pollutant, Bull Environ Contam Toxicol, 51 (1993) 361.
43. Sumpter J P & Jobling S, Vitellelogenesis as a biomarker for estrogenic contamination of the aquatic environment, Environ Health Prespect, 103 (1995) 173.
44. Panter G H, Thomson R S & Sumpter J P, Adverse reproductive effects in male fathead minnows Pimephales promelas exposed to environmentally relevant concentrations of the natural oestrogens, estradiol and oestrone, Aquat Toxicol, 42 (1998) 243.
45. Wibe A E, Rosenqvist G & Jenssen B M, Disruption of reproductive behavior in threespine stickleback Gasterosteus aculeatus exposed to 17β-estradiol, Environ Res, 90 (2002) 136.
46. Mylchreest E, Sar M, Cattley R C & Foster P M, Disruption of androgen-regulated male reproductive development by di(n-butyl)phthalate during late gestation in rats is different from flutamide, Toxicol Appl Pharmacol, 156 (1999) 81.
47. Yamasaki K, Sawaki M, Noda S, Muroi T, Takakura S, Mitoma H, Sakamoto S, Nakai M & Yakabe Y, Comparison of the Hershberger assay and androgen receptor binding assay of twelve chemicals, Toxicology, 195 (2004) 177.
48. Yamasaki K, Takeyoshi M, Yakabe Y, Sawaki M, Imatanaka M, Shinoda K & Takatsuki M, Immature rat uterotrophic assay of eighteen chemicals and Hershberger assay of thirty chemicals, Toxicology, 183 (2003) 95.
49. Wilson V S, Lambright C, Furr J, Ostby J, Wood C, Held G & Gray L E Jr, Phthalate ester-induced gubernacular lesions are associated with reduced ins13 gene expression in the fetal testis, Toxicol Lett, 156 (2004) 207.
50. Weihua Z, Makela S, Anderson L C, Salmi S, Saji S, Webster J I, Jensen E V, Nilsson S, Warner M & Gustafsson J A, A role for estrogen receptor β in the regulation of growth of the ventral prostrate, Proc Natl Acad Sci, USA 98 (2001) 6330.
51. Williams K, McKinnell C, Saunders P T, Walker M, Fisher J S, Turner K J, Atanassova N & Sharpe M, Neonatal exposure to potent and environmental oestrogens and abnormalities of the male reproductive system in the rat: evidence for importance of the androgen-oestrogen balance and assessment of the relevance to man, Hum Reprod Update, 7 (2001) 236.
52. Lee P C, Disruption of male reproductive tract development by administration of the xenoestrogen, nonylphenol, to male newborn rats, Endocrine, 9 (1998) 105.
53. Negishi T, Kawasaki K, Suzaki S, Maeda H, Ishii Y, Kyuwa S, Kuroda Y & Yoshikawa Y, Behavioral alterations in response to fear-provoking stimuli and tranylcypromine induced by perinatal exposure to bisphenol A and nonylphenol in male rats, Environ Health Prespect, 112 (2004) 1159.
54. Brinbaum L S, The mechanism of dioxin toxicity: relationship to risk assessment, Environ Health Prespect, 102 (1997) 157.
55. Kitajima M, Khan K N, Fujishita A, Masuzaki H & Ishimaru T, Histomorphometric alternation and cell-type specific modulation of arylhydrocarbon receptor and estrogen receptor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 17β-estradiol in mouse experimental model of endometriosis, Reprod Toxicol, 18 (2004) 793.
56. Schreurs R, Lanser P, Seinen W & Van Der Burg B, Estrogenic activity of UV filters determined by an in vitro reporter gene assay and in vivo transgenic zebrafish assay, Arch Toxicol, 76 (2002) 257.
57. Ibarreta D, Daxenberger A & Meyer H H, Possible health impact of phytoestrogens and exnoestrogens in food, APMIS, 109 (2001) 161.
58. You L, Phytoestrogen genistein and its pharmacological interactions with synthetic endocrine-active compounds, Curr Pharm Des, 10 (2004) 2749.
59. Kuiper G, Lemmen J G, Carlsson B, Corton J C, Safe S H, van der Saag, P T, van der Berg B & Gustafsson J A, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β, Endocrinology, 139 (1998) 4252.
60. Morton M S, Arisaka O, Miyake N, Morgon L D & Evans B A, Phytoestrogen concentrations in serum from Japanese men and women over forty tears of age, J Nutr, 132 (2002) 3168.
61. Liu D, Homan L L & Dillon J S, Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic AMP dependent mechanism, Endocrinology, (2004) in press.
62. Merritt J C, Metabolic syndrome: soybean foods and serum lipids, J Natl Med Assoc, 96 (2004) 1032.
63. Ewies A A, Phytoestrogens in the management of the menopause: Up-to-date, Obstet Gynaec Survey, 57 (2002) 306.
64. Wuttke W, Jarry H, Westphalen S, Christoffel V & Seidlova-Wuttke D, Phytoestrogens for hormone replacement therapy? J Steroid Biochem Mol Biol, 83 (2003) 133.
65. Lee S H, Jung B H, Kim S Y & Chung B C, Determination of phytoestrogen in traditional medicinal herbs using gas chromatography-mass spectrometry, J Nutr Biochem, 15 (2004) 452.
66. Parks L G, Lambright C S, Orlando E F, Guillette L J J, Ankley G T & Gray L E J, Masculinization of female mosquito in kraft mill effluent-contaminated Fenholloway River water is associated with androgen receptor agonist activity, Toxicol Sci, 62 (2001) 257.
67. Rana T, Gupta S, Kumar D, Sharma S, Rana M, Rathore V S & Pereira B M J, Toxic effects of pulp and paper-mill effluents on male reproductive organs and some systemic parameters in rats, Environ Toxicol Pharmacol, (2004) in press.
68. Körner W, Vinggaard A M, Térouanne B, Ma R, Wieloch C, Schlumpf M, Sultan C & Soto A M, Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals, Environ Health Prespect, 112 (2004) 695.
69. Gray L E J, Ostby J, Furr J, Wolf C J, Lambright C, Parks L, Veeramachaneni D N, Wilson V, Proce M, Hotchkiss A Orlando E & Guillette L, Effects of environmental antiandrogens on reproductive development in experimental animals, Hum Reprod Update, 7 (2001) 248.
70. Fisher J S, Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome, Reproduction, 127 (2004) 305.
71. Hotchkiss A K, Ostby J S, Vandenburg J G & Gray J E J, Androgens and environmental antiandrogens affect reproductive development and play behavior in the Sprague-dawley rat, Environ Helth Prespect, 110 (2002) 435.
72. Juul A & Skakkebaek N E, Androgens and the ageing male, Hum Reprod, Update, 8 (2002) 423.
73. You L, Casanova M, Archibeque-Engle S,Sar M, Fan L Q & Heck H A, Impaired male sexual development in perinatal Sprague-Dawley and Long-Evans hooded rats exposed in utero and lactationally to p,p′-DDE, Toxicol Sci, 45 (1998) 162.
74. Gray L E J, Wold C, Lambright C, Mann P, Price M, Cooper R L & Ostby J, Administration of potentially antiandrogenic pesticides (Procymidone, linuron, iprodione, chlozolinate, p,p′-DDE, and ketoconazole) and toxic substances (dibutyl-and dithylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat, Toxicol Industrial Helth, 15 (1999) 94.
75. McIntyre B S, Barlow N J, Sar M, Wallace D G & Foster P M, Effects of in utero linuron exposure on rat Wolffian duct development, Reprod Toxicol, 16 (2002) 131.
76. Gray L E J, Ostby J, Furr J, Price M, Veeramachaneni D N & Parks L, Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP or DOTP, alters sexual differentiation of the male rat, Toxicol Sci, 58 (2000) 350.
77. Eli C & Nisula B C, The binding properties of pyrethroids to human skin fibroblast androgen receptors and to sex hormone binding globulin, J Steroid Biochem Mol Biol, 35 (1990) 409.
78. Tyler C R, Beresford N, Van der Woning M, Sumpter J P & Thorpe K, Metabolism and environmental degradation of pyrethroid insecticides produce compounds with endocrine activities, Environ Toxicol Chem, 19 (2000) 801.
79. Vinggaard A M, Hnida C & Larsen J C, Environmental polycyclic aromatic hydrocarbons affect androgen receptor activation in vitro, Toxicology, 145 (2000) 159.
80. Paris F, Balaguer P, Térouanne B, Servant N, Lacoste C, Cravedi J, Nicolas J C & Sultan C, Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit alpha and beta estrogen activities and antiandrogen activity in reporter cell lines, Mol Cell Endocr, 193 (2002) 43.
81. Roy P, Salminen H, Koskimies P, Simola J, Smeds A, Saukko P & Huhtaniemi I T, Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay, J Steroid Biochem Mol Biol, 88 (2004) 157.
82. Fischer B, Receptor-mediated effects of chlorinated hydrocarbons, Andrologia, 32 (2000) 279.
83. Gullet B K, Lemieux P M, Lutes C C, Winterrowd C K & Winters D L, Emissions of PCDD/F from uncontrolled, domestic waste burning, Chemosphere, 43 (2001) 721.
84. Diliberto J J, Abbot B D & Birnbaum L S, Use of AhR knockout (AhR-/-) mice to investigate the role of AhR receptor on the disruption of TCDD, Organo Comp, 49 (2000) 121.
85. Sugawara T, Nomura E, Sakuragi N & Fujimoto S, The effect of the arylhydrocarbon receptor on the human steroidogenic acute regulatory gene promoter activity, J Steroid Biochem Mol Biol, 78 (2001) 253.
86. Meerts I A, Assink Y, Cenijin P H Van Den Berg J H, Weijers B M, Bergman A, Koeman J H & Brouwer A, Placental transfer of hydroxylated polychlorinated biphenyl and effects on fetal and maternal thyroid hormone homeostasis in rats. Toxicol Sci, 68, (2002) 361.
87. Gazouli M, Yao Z X, Boujard N, Corton J C, Culty M & Papadopoulos V, Effect of perxisome proliferators on Leydig cells peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: Role of the peroxisome proliferators-activator receptor α, Endocrinology, 143 (2002) 2571.
88. Makela T H, Wahala K T & Hase T A, Synthesis of enterolactone and enterodiol precursors as potential inhibitors of human estrogen synthase (aromatase), Steroids, 65 (2002) 437.
89. Whitehead S A, Cross J E, Burden C & Lacey M, Acute and chronic effects of genistein, tryptophan and lavendustinA on steroid synthesis in luteinized human granulose cells, Hum Reprod, 17 (2002) 589.
90. Ren M Q, Kuhn G, Wegner J & Chen J, Isoflavones, substances with multi-biological and clinical properties, Eur J Nutr, 40 (2001) 135.
91. Carusi D, Phytoestrogens as hormone replacement therapy: an evidence-based approach, Prim Care Update Obstet/Gynaecol, 7 (2000) 253.
92. Weidner I S, Møller H, Jensen T K, Skakkebaek N E, Cryptorchidism and hypospadias in sons of gardeners and farmers, Envrion Helth Prespect, 106 (1998) 793.
93. Garcia-Rodriguez J, Garcia-Martin M, Nogueras-Ocana M, de Dios Luna-del-Castillo J, Espigares G M, Olea N & Iardelli-Claret P, Exposure to pesticides and cryptorchidism: geographical evidence of a possible association, Environ Helth Prespect, 104 (1996) 1090.
94. Skakkabaek N E, Rajpert-De M E & Main K M, Testicular dysgenesis syndrome: an increasing common developmental disorder with environmental aspects, Hum Reprod, 16 (2001) 972.
95. Carlsen E, Giwercman A, Keiding N & Skakkebaek N E, Evidence for the decreasing quality of semen during the past 50 years, Br Med J, 305 (1992) 609.
96. Olsen G W, Bodner K M, Ramlow J M, Ross C E & Lipshultz L I, Have sperm counts been reduced 50 percent in 50 years? A statistical model revisited. Fertil Steril, 63 (1995) 887.
97. Swan S H, Elkin E P & Fenster L, Have sperm densities declined? A reanalysis of global trend data, Environ Helth Prespect, 105 (1997) 1228.
98. Van Waeleghem K, De Clercq N, Vermeulen L, Schoonjans F & Comhaire F, Deterioration of sperm quality in young healthy Belgian men, Hum Reprod, 11 (1996) 325.
99. Pajarinen J, Laippala P, Penttila A & Karhunen P J, Incidence of disorders of spermatogenesis in middle aged Finnish men, 1981-91: two necroscopy series, Br Med J, 314 (1997) 13.
100. Auger J & Jouannet P, Evidence for regional differences of semen quality among fertile French men. Federation Francaise des humains. Hum Reprod, 12 (1997) 740.
101. Andersen A G, Jensen T K, Carlsen E, Jorgensen N, Andersson A M, Krarup T, Keiding N & Skakkebaek N E, High frequency of sub-optimal semen quality in unselected population of young men, Hum Reprod, 15 (2000) 366.
102. Safe S, Environmental estrogens: roles in male reproductive tract problems and in breast cancer, Rev Environ Helth, 17 (2002) 253.
103. Uzumcu M, Suzuki H & Skinner M K, Effect of anti-androgenic endocrine disruptor vinclozoline on embryonic testis cord formation and postnatal testis development and function, Reprod Toxicol, 18 (2004) 765.
104. Bibbo M, Haenszel W M, Wied G L, Hubby M & Herbst A L, A twenty-five years follow-up study of women exposed to diethylstilbestrol during pregnancy, N Eng J Med, 298 (1978) 763.
105. Dallinga J W, Moonen E J, Dumoulin J C, Evers J L, Geraedts J P & Kleinjans J C, Decreased human semen quality and organochlorine compounds in blood, Hum Reprod, 17 (2002) 1973.
106. Swan S H, Brazil C, Drobnis E Z, Liu F, Kruse R L, Hatch M, Redmon J B, Wang C & Overstreet J W, Geographic differences in semen quality of the fertile US males, Environ Helth Prespect, 111 (2003) 414.
107. Bergstrom R, Adami H O, Mohner M, Zatonski W, Strom H, Ekbom A, Tretli S, Teppo L, Akre O & Hakulinen T, Increase in testicular cancer incidence in six European countries: A birth cohort phenomenon, J Nat Cancer Inst, 88 (1996) 727.
108. SEER, SEER Cancer Statistics Review, 1975-2000, http://seer.cancer.gov/ csr/1975_2000, Bethesda, MD: National Cancer Institute (2003).
109. McKiernan J M, Goluboff E T, Liberson G L, Golden R & Fisch H, Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995, J Urol, 162 (1999) 361.
110. Sharpe R M, The 'oestrogen hypothesis' - where do we stand now? Int J Androl, 26 (2003) 2.
111. Ohlson C G & Hardell L, Testicular cancer and occupational exposures with a focus on xenoestrogens in polyvinyl chloride plastics, Chemosphere, 40 (2000) 1277.
112. Schwartz G G, Hypothesis: does ochratoxin A cause testicular cancer? Cancer Cause Control, 13 (2002) 91.
113. Toppari J, Kaleva M & Virtanen H E, Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data, Hum Reprod Update, 7 (2001) 282.
114. Sharpe R M, Mckinnell C, Kivlin C & Fisher J S, Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood, Reproduction, 125 (2003) 769.
115. Hoise S, Loff S, Witt K, Niessen K & Waag K L, Is there a correlation between organochlorine compounds and undescended testes? Eur J Paed Surg, 10 (2000) 304.
116. Jensen T K, Toppari J, Keiding N & Skakkebaek N E, Do environmental estrogens contribute to decline in male reproductive health? Clin Chem, 41 (1995) 1896.
117. Paulozzi L J, Erickson J D & Jackson R J, Hypospadias trends in two US surveillance systems, Paediatrics, 100 (1997) 831.
118. Dearnaley, D, Huddart R A & Horwich A, Regular review: Managing testicular cancer, Br Med J, 322 (2001) 1583.
119. Klip H, Verloop J, van Gool J D, Koster M E, Burger C W & van Leeuwen F E, Hypospadias in sons of women exposed to diethylstilbestrol in utero: A cohort study, Lancet, 359 (2002) 1102.
120. Steinhardt G F, Endocrine disruption and hypospadias, Adv Exp Med Biol, 545 (2004) 203.
121. Davis D L, Gottlieb M B & Stampnitzky J R, Reduced ratio of male to female births in several industrial countries: a sensational health indicator? JAMA, 279 (1998) 1018.
122. Martuzzi M, Di Tanno N D & Bertollini R, Declining trends of male proportion at birth in Europe, Arch Environ Helth, 56 (2001) 358.
123. Jarrell J F, Gocmen A, Akylol D & Brant R, Hexachlorobenzene exposure and the proportion of male births in Turkey 1935-1990, Reprod Toxicol, 16 (2002) 65.
124. Del Rio-Gomez I, Marshall T, Tsai P, Shao Y S & Guo Y L, Number of boys born to men exposed to polychlorinated biphenyl's, Lancet, 360 (2002) 143.
125. Mocarelli P, Gerthoux P M, Ferrari E, Patterson D G J, Kieszak S M, Brambilla P, Vincoli N, Signorini S, Tramacere P, Carreri V, Sampson E J, Turner W E & Needham L, Paternal concentrations of dioxin and sex ratio of offspring, Lancet, 355 (2000) 1858.
126. Schnorr T M, Lawson C C , Whelan E A, Dankovic D A, Deddens J A Piacitelli L A, Reefhuis J, Swwney M H, Connally B L & Fingerhut M A, Spontaneous abortion, sex ratio, and paternal occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Environ Helth Prespect, 109 (2001) 1127.
127. Singleton D W & Khan S A, Xenoestrogen exposure and mechanisms of endocrine disruption, Front Biosci, January (2003) 1.
128. Laessig S A, McCarthy M M & Silbergeld E K, Neurotoxic effects on endocrine disruptors, Curr Opin Neurol, 12 (1999) 745.
129. Rice D C, Behavioral impairment produced by low-level postnatal exposure in monkeys, Environ Res, 80 (1999) S113.
130. Hany J, Lilienthal H, Roth-Harer A. Ostendorp G, heinzow B & Winneke G, Behavioral effects following single and combined maternal exposure to PCB 77 (3,3,3′,4′-tetrachlorobiphenyl) and PCB 47 (2,4,2′,4′- tetrachlorobiphenyl) in rats, Neurotoxicol Teratol, 21 (1999) 147.
131. Adriani W, Della-Seta D, Dessi-Fulgheri F, Farabollini F & Laviola G, Altered profiles of spontaneous novelty seeking, impulsive behavior, and response to D-amphetamine in rats perinatally exposed to bisphenol A, Environ Helth Prespect, 111 (2003) 395.
132. Ishido M, Masuo Y, Oka S, Niki E & Morita M, p-Nitrotoluene causes hyperactivity in the rat, Neurosci Lett, 366 (2004) 1.
133. OECD, Draft summary report of the sixth meeting of the task force on endocrine disruptors testing and assessment (EDTA 6), Draft as of March 12, 2003.
134. Gray L E J, Ostby J, Wilson V, Lambright C, Bonseine K, Hartig P, Hotchkiss A, Wolf C, Furr J, Price M, Parks L, Cooper R L, Stoker T E, Laws S C, Degitz S J, Jensen K M, Khal M D, Korte J J, Makynen E A, Tietge J E & Ankley G T, Xenoendocrine disruptors-tiered screening and testing, Toxicology, 21 (2002) 371.
135. Wong C, Kelce W R, Sar M & Wilson E M, Androgen receptor antagonist versus agonist activities of the fungicide vinclozoiln relative to hydroxuflutamide, J Biol Chem, 25 (1995) 19998.
136. Scippo M, -L, ArgirisC, Weerdt C V D, Muller M, Willemsen P, Martial J & Rogister G M, Recombinant human estrogen, androgen and progesterone receptors for detection of potential endocrine disruptors, Anal Bioanal Chem, 378 (2004) 664.
137. Freyberger A & Ahr H -J, Development and standardization of a simple binding assay for the detection of compounds with affinity for the androgen receptor, Toxicology, 195 (2004) 113.
138. Lippman M & Huff K, A demonstration of androgen and estrogen receptors in human breast cancer using a new protamine sulfate assay, Cancer, 38 (1976) 868.
139. Soto A M, Sonnenschein C, Chung K L, Fernandez M F, Olea N & Serrano F O, The E-Screen assay as a tool to identify estrogens: an update on estrogenic environmental pollutants, Environ Helth Prespect, 103 (1995) 113.
140. Desaulniers D, Leingartner K, Zacharewski T & Foster W G, Optimization of an MCF7-E3 cell proliferation assay and effects of environmental pollutants and industrial chemicals, Toxicol In Vitro, 12 (1998) 409.
141. Rasmussen T H & Nielsen J B, Critical parameters in the MCF-7 cell proliferation bioassay (E-Screen), Biomarkers, 7 (2002) 322.
142. Zachaarewski T R, In vitro bioassays for assessing estrogenic substances, Environ Sci Tech, 272 (1997) 5122.
143. Sohini P & Sumpter J P, Several environmental oestrogens are also anti-androgens, J Endocrinol, 158 (1998) 327.
144. Metzger D, White J H & Chambon P, The human estrogen receptor functions in yeast, Nature, 334 (1998) 31.
145. Hoogenboom LAP, DeHaan L, Hooijerink D, Bor G, Murk A J & Brouwer A, Estrogenic activity of estradiol and its metabolites in the ER-CALUX assay with human T47D breast cells, APMIS, 109 (2001) 101.
146. Vinggaard A M, Joergensen E C B & Larsen J C, Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals, Toxicol Appl Pharmacol, 155 (1999) 150.
147. Bovee T F H, Helsdingen R J R, Koks P D, Kuiper H A, Hoogenboom R L A P & Keijer J, Development of a rapid yeast estrogen bioassay based on the expression of green fluorescent protein, Gene, 325 (2004) 187.
148. Owens J W & Ashby J, Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for economic co-operation and development, Crit Rev Toxicol, 32 (2002) 445.
149. Hershberger L, Shipley E & Meyer R, Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method, Proc Soc Exp Biol Med, 83 (1953) 175.
150. Dorfman R, Androgens and anabolic agents. in, Methods in Hormone Research, Bioassays II, edited by R Dorfman (Academic Press, New York) 275.
151. Tabata Y, Iizuka Y, Masuda N T, Shinei R, Kurihara K, Okonogi T, Hoshiko S & Kurata Y, In vitro and in vivo characterization of novel nonsteroidal progesterone receptor agonists derived from the fungal metabolite PF1092C, J Steroid Biochem Mol Biol, 82 (2002) 217.
152. Hutchinson T H, Brown R, Brugger K E, Campbell P M, Holt M, Lange R, McCahon P, Tattersfield L J & van Egmond R, Ecological risk assessment of endocrine disruptors, Environ Helth Prospect, 108 (2000) 1007.
153. Hemmer M J, Bowman C J, Hemmer B L, Friedman S D, Marcovich D, Kroll K J & Denslow N D, Vitellogenin mRNA regulation and plasma clearance in male sheepshead minnows, (Cyprinodon variegatus) after cessation of exposure to 17 beta-estradiol and p-nonylphenol, Aquat Toxicol, 58 (2002) 99.
154. Capen C S, Correlation of mechanistic data and histopathology in the evaluation of selected toxic endpoints of the endocrine system, Toxicol Lett, 102-103 (1998) 405.
155. Yaoita Y & Nakajima K, Induction of apoptosis and CPP32 expression by thyroid hormone in a myoblastic cell line derived from tadpole tail, J Biol Chem, 272 (1997) 5122.
156. Kaminuma T, Takai-Tgarashi T, Nakano T & Kakata K, Modeling of signaling pathways for endocrine disruptors, Biosystems, 55 (2000) 23.
157. Sanderson H, Johnson D J, Reitsma T, Brain R A, Wilson C J & Solomon K R, Ranking and prioritization of environmental risks of pharmaceuticals in surface waters, Regul Toxicol Pharmacol, 39 (2004) 158.
158. Nakata K, Theoretical approach to endocrine disruptors, Front Biosci, 7 (2002) 68.
159. Parks L G, Ostby J S, Lambright C R, Abbott B D, Klinefelter G R, Barlow N J & Gray L E J, The platicizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat, Toxicol Sci, 58 (2000) 339.
160. Lambright C, Ostby J, Bobseine K, Wilson V, Hotchkiss A K, Mann P C & Gray L E J, Cellular and molecular mechanisms of action of linuron: An antiandrogenic herbicide that produces reproductive malformations in male rats, Toxicol Sci, 56 (2000) 289.